Advisor Group Holdings, Inc. Autolus Therapeutics PLC Transaction History
Advisor Group Holdings, Inc.
- $42.1 Billion
- Q1 2025
A detailed history of Advisor Group Holdings, Inc. transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 21,724 shares of AUTL stock, worth $38,017. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,724Holding current value
$38,017% of portfolio
0.0%Shares
14 transactions
Others Institutions Holding AUTL
# of Institutions
99Shares Held
163MCall Options Held
0Put Options Held
88.3K-
Wellington Management Group LLP Boston, MA27.1MShares$47.4 Million0.01% of portfolio
-
Blackstone Inc New York, NY20.5MShares$35.8 Million0.14% of portfolio
-
Deep Track Capital, LP Greenwich, CT17.8MShares$31.2 Million0.97% of portfolio
-
Syncona Portfolio LTD Guernsey, Channel Islands, X016.6MShares$29.1 Million97.79% of portfolio
-
Armistice Capital, LLC New York, NY11MShares$19.3 Million0.26% of portfolio
About Autolus Therapeutics plc
- Ticker AUTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 90,909,800
- Market Cap $159M
- Description
- Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...